Multilevel Bayesian Models for Survival Times and Longitudinal Patient-Reported Outcomes With Many Zeros
Regulatory approval of new therapies often depends on demonstrating prolonged survival. Particularly when these survival benefits are modest, consideration of therapeutic benefits to patient-reported outcomes (PROs) may add value to the traditional biomedical clinical trial endpoints. We extend a popular class of joint models for longitudinal and survival data to accommodate the excessive zeros common in PROs, building hierarchical Bayesian models that combine information from longitudinal PRO measurements and survival outcomes. The model development is motivated by a clinical trial for malignant pleural mesothelioma, a rapidly fatal form of pulmonary cancer usually associated with asbestos exposure. By separately modeling the presence and severity of PROs, using our zero-augmented beta (ZAB) likelihood, we are able to model PROs on their original scale and learn about individual-level parameters from both presence and severity of symptoms. Correlations among an individual's PROs and survival are modeled using latent random variables, adjusting the fitted trajectories to better accommodate the observed data for each individual. This work contributes to understanding the impact of treatment on two aspects of mesothelioma: patients’ subjective experience of the disease process and their progression-free survival times. We uncover important differences between outcome types that are associated with therapy (periodic, worse in both treatment groups after therapy initiation) and those that are responsive to treatment (aperiodic, gradually widening gap between treatment groups). Finally, our work raises questions for future investigation into multivariate modeling, choice of link functions, and the relative contributions of multiple data sources in joint modeling contexts.
If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
As the access to this document is restricted, you may want to look for a different version under "Related research" (further below) or search for a different version of it.
Volume (Year): 107 (2012)
Issue (Month): 499 (September)
|Contact details of provider:|| Web page: http://www.tandfonline.com/UASA20|
|Order Information:||Web: http://www.tandfonline.com/pricing/journal/UASA20|
When requesting a correction, please mention this item's handle: RePEc:taf:jnlasa:v:107:y:2012:i:499:p:875-885. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Chris Longhurst)
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If references are entirely missing, you can add them using this form.
If the full references list an item that is present in RePEc, but the system did not link to it, you can help with this form.
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your profile, as there may be some citations waiting for confirmation.
Please note that corrections may take a couple of weeks to filter through the various RePEc services.